In8Bio (INAB) Net Equity Issued and Repurchased (2020 - 2025)

In8Bio has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $102000.0 in Q4 2025.

• Quarterly Net Equity Issued and Repurchased fell 97.39% year-over-year to $102000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4.8 million (down 36.02% YoY) and the FY2025 annual result came in at $8.6 million, up 124.48% from the prior year.
• Net Equity Issued and Repurchased declined to $102000.0 in Q4 2025 per INAB's latest filing, from $1.1 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $36.3 million in Q4 2021 and troughed at -$3.6 million in Q3 2024.
• A 5-year average of $4.8 million and a median of $1.9 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2021 and 2024: Net Equity Issued and Repurchased surged 71129.41% in 2021, then tumbled 291.58% in 2024.
• Over 5 years, Net Equity Issued and Repurchased stood at $36.3 million in 2021, then sank by 73.9% to $9.5 million in 2022, then tumbled by 99.34% to $63000.0 in 2023, then surged by 6098.41% to $3.9 million in 2024, then sank by 97.39% to $102000.0 in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $102000.0, $1.1 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.